MED Institute, a leader in medical product development services, announces a significant leadership transition as esteemed President Neal Fearnot retires after over 40 years of dedicated service. Under his visionary leadership, MED Institute has grown into a trusted partner for medical innovators, advancing product development worldwide.

Steve Charlebois has been appointed as the new President. Steve previously served as Vice President and brings 25 years of experience in the medical product development industry. His expertise and leadership will be invaluable as we continue to innovate and grow.

David Gross has been named Vice President. David has played a crucial role in directing MRI Safety Evaluations and Computational Modeling and Simulation (CM&S) groups, contributing to the company’s reputation for technical excellence and cutting-edge technologies.

Scott Williams has been named Vice President, Regulatory/Clinical Services. With his 20+ years of experience in clinical studies and regulatory affairs, Scott has established a respected reputation with regulators and has guided approval/clearance of several currently-marketed products with significant impact on patient care.

“This transition marks an exciting new chapter for MED Institute,” said Steve Charlebois, President. “We remain dedicated to advancing medical technology and delivering the highest level of support to our clients. I look forward to building upon the strong foundation that Neal has established.”

Throughout this transition, MED Institute remains committed to maintaining the same excellence, reliability, and expertise that its collaborators and clients have come to expect. For more information, please contact Brooke Corcoran at bcorcoran@medinstitute or visit medinstitute.com.

About MED Institute

MED Institute accelerates product development and is dedicated to bringing new medical products to the market that are safe and effective for patients. From concept to commercialization, our team has the knowledge and experience to guide your product through the complex steps required for market approval.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250224681999/en/